← All Si-bone, INC filings

Si-bone, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
SIBN
Si-bone, INC
DEF: SI-BONE Invites Stockholders to 2026 Annual Meeting
SI-BONE, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 4, 2026, highlighting significant 2025 financial and operational achievements.
NASDAQ
SIBN
Si-bone, INC
DEFA14A: SIBN Proxy Statement Filed for 2025 Annual Meeting
SIBN has filed its proxy statement for the upcoming 2025 annual meeting, detailing matters for shareholder consideration.
NASDAQ
SIBN
Si-bone, INC
DEF: SI-BONE Reports Strong 2024 Revenue Growth and Improved Profitability, Announces Annual Meeting
SI-BONE's 2024 saw a 20% revenue increase, significant physician adoption of iFuse procedures, and substantial improvements in net loss and adjusted EBITDA.
NASDAQ
SIBN
Si-bone, INC
DEFA14A: SI-BONE, Inc. Files Definitive Proxy Statement with SEC
SI-BONE, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) regarding its upcoming shareholder meeting.
NASDAQ
SIBN
Si-bone, INC
DEF 14A: SI-BONE, Inc. Announces 2024 Annual Meeting of Stockholders, Outlines Key Business Achievements and Governance Proposals
SI-BONE, Inc. has scheduled its 2024 Annual Meeting of Stockholders for June 25, 2024, and the proxy statement details key business achievements, director nominations, and governance proposals.